Katie studied biochemistry at the University of Oxford, before joining a lab to investigate why the immune system can’t control HIV. She then worked in science communication for the MS Society and joined Cancer Research UK’s News and Content team in 2017, where she writes for the blog and news feed.
This week’s news: cancer survival in England still lags behind the best and a second immunotherapy drug is made available for advanced skin cancer on the NHS.
In the news this week: NHS staff shortages could reach 350,000 by 2030 and an error meant almost 50,000 women weren’t sent cervical screening letters.
We don’t always know why never-smokers develop lung cancer, but the data suggests that genetics play a role, as well as environmental or occupational exposures.
In the news this week: drug approvals could be delayed by a ‘no-deal’ Brexit and scientists investigating DNA faults have uncovered some surprising results.
The time it takes for cancer to develop will vary from tumour to tumour. But on the whole, it’s slower than you might expect.
Professor George Smith and Sir Gregory Winter won a Nobel Prize for a developing a technique that can help scientists discover new cancer drugs.
In the news this week: Nobel Prize for Medicine awarded to scientists who laid the groundwork for cancer immunotherapy.
New figures suggest that obesity could top smoking as the biggest preventable cause of cancer in women by 2043. Here’s how we calculated them.
In the news this week: New global cancer figures revealed and a study sheds new light on which faults in the BRCA1 gene could increase cancer risk.
In the news this week: engineered cell therapy given initial ‘no’ for NHS in England and we publish our research highlights in our 2017/18 annual review.